Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-15, Stock:PFE, The news for the past five days is as follows:
2021-11-08: NEWS1: U.S. administers 432 mln COVID-19 vaccine doses, 70% adults fully vaccinated- CDC.NEWS2: Why Novavax Stock Jumped Today.NEWS3: IBD/TIPP Poll: Vaccine Holdouts Dig In With Pfizer, Merck Antiviral Pills Looming.NEWS4: Merck Stock Tumbles On Pfizer Rivalry In Covid Antivirals — Is It A Buy Now?.NEWS5: Moderna Takes A Beating On Mounting Vaccine Challenges — Is It A Buy Or A Sell?.NEWS6: Travel 'confidence level' is surging amid COVID-19 vaccinations: Vacasa CEO.NEWS7: Pfizer Stock Gaps Higher On Covid Pill Enthusiasm — Is It A Buy Now?.NEWS8: Coronavirus: Infectious diseases physician details the latest news and therapeutics in pandemic.NEWS9: Merck Ahead Of Pfizer In Talks With Europe For COVID-19 Pills: Reuters.NEWS10: Why BioNTech Stock Is Bouncing Back Today.NEWS11: 5 ETFs Sizzling to Start November.NEWS12: Pfizer (PFE) COVID Pill Shows Strong Efficacy, Stock Rallies.NEWS13: Regeneron’s Covid Drug Could Be an Alternative to Vaccines.NEWS14: COVID testing costs, hospitalization to drop as treatments enter market: Analyst.NEWS15: COVID-19 pill: Pfizer plans to file for authorization by Thanksgiving.NEWS16: More Good Covid Treatment News; Markets Up Again.NEWS17: Merck ahead of Pfizer in EU talks on COVID-19 pills -EU source.NEWS18: Stock Market News for Nov 8, 2021.NEWS19: Regeneron Drug Could Be an Alternative to Covid Vaccines for Immunocompromised.NEWS20: UPDATE 1-Singapore to decide on COVID-19 vaccine for children aged 5 to 11 this month.NEWS21: Three Encouraging News on U.S. Economic Recovery: 5 Top Picks.NEWS22: Do These 2 Numbers From Pfizer Spell Trouble for Moderna?.NEWS23: Travel stocks fall even as US reopens border to UK flights.NEWS24: Pfizer’s Covid Pill Is Shaking Up the Asia Recovery Trade.NEWS25: Investors are betting that Pfizer’s ‘game-changing’ antiviral pill will reduce demand for COVID vaccines.
2021-11-09: NEWS1: Pfizer to apply for COVID vaccine use in Brazil for children 5-11 years.NEWS2: Why Biohaven Pharmaceuticals Stock Crumbled On This Premium Deal With Pfizer.NEWS3: Pfizer, BioNTech Ask FDA to Expand Covid-19 Booster Use to All Adults.NEWS4: U.S. administers 433.2 mln doses of COVID-19 vaccines - CDC.NEWS5: UPDATE 2-Pfizer seeks FDA nod for COVID vaccine boosters for U.S. adults.NEWS6: Pfizer and BioNTech seek backing of COVID-19 booster for those 18 and over, as U.S. deaths continue to average 1,200 a day.NEWS7: Pfizer asks FDA to authorize COVID-19 booster shot for all adults.NEWS8: REFILE-Pfizer, BioNTech again seek U.S. nod for COVID-19 vaccine boosters in all adults.NEWS9: UPDATE 1-Canada authorizes Pfizer COVID vaccine booster for adults.NEWS10: Pfizer Asking FDA To Approve Booster Shots For All Adults.NEWS11: BioNTech stock reverses lower after earnings report, in which profit and revenue beat expectations.NEWS12: Pfizer and BioNTech to seek backing of COVID-19 booster for those 18 and over, as U.S. deaths continue to average 1,200 a day.NEWS13: Pfizer Gains Outside US Rights To Biohaven's Migraine Treatment For $500M.NEWS14: One year from Pfizer vaccine news, some unlikely market outcomes.NEWS15: BioNTech Stock Is Getting a Lift. Earnings Were Strong..NEWS16: UPDATE 2-Pfizer to market Biohaven's migraine drugs overseas.NEWS17: Biohaven's stock slides 15% on deal with Pfizer for its migraine drug.NEWS18: Biohaven, Pfizer enter up to $1.24 billion deal to market migraine drugs.NEWS19: Better COVID Stock: Merck vs. Pfizer.NEWS20: Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States.NEWS21: The Zacks Analyst Blog Highlights: Tesla, Nucor, Gartner, ON Semiconductor and CBRE Group.NEWS22: BioNTech sees up to 17 billion eur in vaccine revenue this year.NEWS23: BioNTech sees up to 17 billion eur in vaccine revenue this year.NEWS24: Merck stock rallies after U.S. plans to buy 1.4 million more COVID-19 pill courses for $1 billion if authorized.NEWS25: Should You Buy Pfizer Stock After the Fantastic COVID-19 Pill News?.NEWS26: UPDATE 1-French health authority advises against Moderna COVID-19 vaccine for under 30s.NEWS27: Three Key Pieces of Evidence Presented at Elizabeth Holmes’s Trial.NEWS28: A Year After Vaccine Jolt, Bet on Value Stocks Disappoints.NEWS29: French health authority advises against Moderna COVID-19 vaccine for under 30s.
2021-11-10: NEWS1: Dr. Sanjay Gupta on combating COVID-19 vaccine misinformation.NEWS2: Nasdaq Leads Stocks Lower, Pfizer, BioNTech Top S&P 500; Affirm Holdings Rebounds In After-hours Trade.NEWS3: Pfizer Seeks Covid Boosters For All; But How Long Is The Opportunity?.NEWS4: U.S. administers 434.5 mln doses of COVID-19 vaccines - CDC.NEWS5: Investing in Pfizer Stock (PFE).NEWS6: U.S. to Ship J&J Shot to Hot Spots; Italy Boosters: Virus Update.NEWS7: Novavax asks for FDA meeting after first global authorization for COVID-19 vaccine: CEO.NEWS8: Biotech Stock Roundup: REGN, MRNA Post Q3 Earnings, SAVA Gains on AD Review Data.NEWS9: Novavax CEO: We aim to complete the FDA filing for our COVID vaccine this year.NEWS10: White House says 900,000 5- to 11-year-olds were vaccinated during first week of eligibility for scaled-down dose.NEWS11: Pfizer asks the FDA to authorize its COVID booster shot for adults.NEWS12: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS13: Biohaven (BHVN) Misses on Q3 Earnings, Inks $1.24B Pfizer Deal.NEWS14: UPDATE 2-Germany recommends only Biontech/Pfizer vaccine for under-30s.NEWS15: Germany Recommends Pfizer/BioNTech Vaccine Over Moderna's.NEWS16: GeoVax Labs In-Licenses Development Rights To Multi-Antigenic COVID-19 Vaccine Candidate.NEWS17: 3 Rock-Solid Healthcare Dividend Stocks Now on Sale.NEWS18: Could Pfizer's COVID Pill Be Even Bigger Than Its Vaccine?.NEWS19: CORRECTED-UPDATE 1-Germany recommends only Biontech/Pfizer vaccine for people under 30.NEWS20: Germany recommends only Biontech/Pfizer vaccine for people under 30.NEWS21: Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan.NEWS22: BioNTech SE (BNTX) Q3 2021 Earnings Call Transcript.
2021-11-11: NEWS1: Moderna Stock Falls Back to Earth as Questions Mount.NEWS2: Next Level Benefits CEO: 'Employers are going to need to pay for' COVID-19 testing at work.NEWS3: Moderna Says COVID-19 Vax Associated With Fewer Cases Than Pfizer's, But Higher Inflammatory Heart Conditions.NEWS4: Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana.NEWS5: Drones Ferry Pfizer’s Precious, Deep-Frozen Vaccine to Africa’s Remote Villages.NEWS6: Merck (MRK) Inks $1.2B COVID-19 Pill Supply Deal With Japan.NEWS7: The Zacks Analyst Blog Highlights: Regeneron, Moderna, Cassava Sciences, Biohaven Pharma and Pfizer.NEWS8: How Pfizer Knocked It Out of the Park in Q3.NEWS9: Should an 11-Year-Old Wait to Get the Bigger Covid-19 Vaccine Dose?.NEWS10: Traders Should Be Stopped Out of Biohaven Pharmaceutical.NEWS11: I’ve already had two Covid jabs, but they don’t count in the UK.
2021-11-12: NEWS1: One in three Americans aged 65 and above has got COVID-19 booster shot: CDC.NEWS2: Best way to minimize COVID-19 risk this holiday season is by getting vaccinated: Doctor.NEWS3: Some states expand booster availability beyond federal recommendations.NEWS4: Johnson & Johnson Pops As It Announces The Biggest Split In Health Care.NEWS5: Moderna vaccine patent dispute: 'It’s a political story. It’s a financial story. It’s a legal story’.NEWS6: Coronavirus: Doctor sees ‘beginning of a wave’ as winter looms.NEWS7: Doctor's holiday gathering advice amid pandemic: 'Being vaccinated goes a long way'.NEWS8: UPDATE 1-WHO to set guidelines on COVID-19 antiviral pills soon.NEWS9: The Johnson & Johnson split ‘makes sense’ as it moves into ‘more innovative products’: Analyst.NEWS10: AstraZeneca has decided to make money from the pandemic after all.NEWS11: Johnson & Johnson Stock Is Gaining Because 2 Companies Might Make More Sense Than 1.NEWS12: Pre-Markets Edge Up on JNJ Split News.NEWS13: Johnson & Johnson Stock Rises on Plan for Breakup.NEWS14: Johnson & Johnson CFO: Splitting company into two is about 'the potential unlocking of value for the consumer health business'.NEWS15: J&J Plans to Split in Two; Dow Up Triple Digits.NEWS16: Johnson & Johnson  to split into two companies, consumer products and medical devices.NEWS17: Johnson & Johnson Stock Jumps on Plan for Breakup.NEWS18: Pharma Stock Roundup: AZN, BAYRY Q3 Results, PFE COVID Pill's Strong Efficacy.NEWS19: 3 Pharma Stocks That Could Make You Richer in November (and Beyond).NEWS20: J&J Pops on Decision to Split Consumer Health Business.NEWS21: AstraZeneca Slips on Q3 Miss, Intends to Start Marking up Covid Vaccine Price.

Answer: Decrease